However, one retrospective cross-sectional study indicated that IBD patients not receiving anti-TNF treatment had higher rates of hepatic steatosis (assessed through abdominal imaging) compared to those undergoing anti-TNF therapy [27]. Here, TNF is linked to inflammatory bowel disease.